Subscribe


Pharmacy Daily

PD breaking news – EBOS to acquire HPS for $154 million

Acquisition complements and extends EBOS’ existing Australian hospital business. 

EBOS has just confirmed a binding agreement for the acquisition of HPS, Australia’s largest provider of outsourced pharmacy services to hospitals. The $154 million purchase “both complements and extends EBOS’ existing Australian hospital business and provides a new platform for expansion in this important market,” the company said.

HPS currently services more than 100 sites and employs over 580 staff, including about 200 pharmacists.

EBOS ceo Patrick Davies said HPS was an important strategic investment “as it provides the Group with a vertically integrated model in a market segment that has attractive long term growth prospects, including the continued introduction of new drugs.

“The acquisition of HPS continues EBOS’ history of expansion in both the Australian and New Zealand hospital markets where it is the leading provider of wholesale pharmaceutical services. By virtue of this acquisition, EBOS will be the leading provider of outsourced pharmacy services in the Australian hospital sector.” Davies said.

The key management of HPS will continue to operate the business under EBOS’ ownership, with HPS forming part of the group’s Institutional Healthcare business division.

More details in tomorrow’s issue of Pharmacy Daily.


The above Breaking News Alert was sent to Pharmacy Daily subscribers on 23 May 17

Make a comment...



Established in 2007, Pharmacy Daily is Australia's leading pharmacy industry publication, and is sent as a free subscription to people across the industry as a PDF newsletter every weekday.

Register for Pharmacy Daily trial subscription

To sign up for a free subscription, click on the button at right.

Click here to see a sample issue of Pharmacy Daily.

Click here for more information on subscriptions.

Alternatively, you can search our site via the search box on the right hand side of the page, or find other content below.

Recent Pharmacy Daily articles

19 Feb

Weekly Comment 19 Feb 18: Promoting your personal brand - THIS week's contributor is Heidi Dariz, General ...


19 Feb

Dispensary Corner 19 Feb 18 - PEOPLE can remain very loyal to their ...


19 Feb

Arthrem safety alert - NEW Zealand Medicines and Medical Devices Safety ...


19 Feb

Roche to buy Flatiron - ROCHE has announced it has signed a ...


19 Feb

Gannon slams vaping - AMA president Michael Gannon has highlighted the ...


19 Feb

FDA guidance x seven - THE US Food and Drug Administration (FDA) ...


19 Feb

Potent new flu vaccine - A NEW high dose influenza vaccine will ...


19 Feb

Schulze WA POTY - FORMER PDL chairman and current chairman of ...


19 Feb

WA Guild elections - NOMINATIONS are open for the election of ...


19 Feb

‘Pharmacy first’ says NHS - PARENTS of young children with minor illnesses ...


19 Feb

Med cannabis challenges - WITH society's growing demand for access to ...


16 Feb

Events Calendar 16 Feb 18 - 16-18 Mar: Annual Therapeutic Update 2018; Fairmont ...


16 Feb

Dispensary Corner 16 Feb 18 - THE man famed for being the fifth ...


16 Feb

Choose pain Rx wisely - NPS MedicineWise has released through its Choosing ...


16 Feb

TRUST FENMOL recall - PHARMACEUTICAL manufacturer Pharmacor in conjunction with the ...


16 Feb

PDL offers free PI - PHARMACEUTICAL Defence Limited is highlighting its offer ...


16 Feb

Bill amended - THE Therapeutic Goods Amendment (2017) Bill was ...


16 Feb

Photopheresis alert - HEALTH professionals and consumers are being advised ...


16 Feb

Opdivo for bladders - THE Therapeutic Goods Administration has announced approval ...


16 Feb

Holista inks $6m deal - ASX-LISTED Perth-based biotech Holista CollTech, focused on ...



Show Pharmacy Daily items by month: